Related Experiment Video
Updated: Apr 14, 2026

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
Published on: August 29, 2017
Natural evolution of broadly neutralizing antibodies
1Ragon Institute of MGH, MIT, and Harvard, Cambridge, MA 02138, USA.
Researchers studied how the body naturally develops broadly neutralizing antibodies against HIV-1. This research offers insights for creating effective HIV-1 vaccines to induce protective antibodies.
Area of Science:
- Immunology
- Virology
- Genomics
Background:
- Broadly neutralizing antibodies (bNAbs) are crucial for controlling HIV-1 infection.
- Understanding the natural selection and evolution of bNAbs is key to developing effective vaccines.
- HIV-1's high mutation rate presents challenges for antibody-based therapies.
Purpose of the Study:
- To elucidate the evolutionary pathways and selection pressures governing the development of HIV-1 broadly neutralizing antibodies.
- To identify key molecular and cellular processes involved in natural bNAb induction.
- To provide a framework for designing vaccine strategies that accelerate protective antibody responses.
Main Methods:
- Utilized next-generation sequencing (NGS) to analyze antibody repertoires.
- Employed structural analysis to understand antibody-antigen interactions.
- Integrated computational modeling with experimental data.
Main Results:
- Identified specific genetic and structural features associated with bNAb development.
- Characterized the selection pressures favoring the emergence of potent neutralizing antibodies.
- Revealed critical stages in the antibody maturation process.
Conclusions:
- The study illuminates the natural mechanisms underlying broadly neutralizing antibody generation against HIV-1.
- Findings provide a roadmap for rational vaccine design to elicit protective humoral immunity.
- Accelerating the induction of effective bNAbs is a viable strategy for HIV-1 prevention.
More Related Videos
06:08Author Spotlight: A Pseudotype Virus System for Assessing Omicron Subvariants and Neutralizing Antibodies in SARS-CoV-2 Research
Published on: September 8, 2023
04:47A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies
Published on: February 23, 2018
Related Concept Videos
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Humoral Immune Responses
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Cross-reactivity
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...